Anualidad
Event
Entity
Process
Conference
Occurrent
Osteoporosis and Breast Cancer: Outcomes at a Specialized Osteoporosis Clinic Following a Structured Assessment.
Practical Skill Session: Crystal analysis II
Osteoporosis and breast cancer: can FRAX-based risk factors accurately predict further fractures at this setting?
GENOME-WIDE ASSOCIATION META-ANALYSIS IDENTIFIES FIVE NEW LOCI FOR SYSTEMIC LUPUS ERYTHEMATOSUS
ADHERENCE, SATISFACTION AND FULFILLMENT OF EXPECTATIONS OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS BIOLOGICALS. ARCO STUDY
A genome-wide association study of gout in people of european ancestry.
SYSTEMATIC REVIEW AND META-ANALYSIS ON CERTOLIZUMAB PEGOL FOR RHEUMATOID ARTHRITIS IN ADULTS
Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort.
Local fracture liaison service (FLS): characteristics and first 6 months of evolution in patients after hip fracture: preliminary results
EFFICACY OF TOCILIZUMAB IN 31 PATIENTS WITH GIANT CELL ARTERITIS
Synovial fluid leukocyte count and its association with crystal deposition in asymptomatic hyperuricemia: a preliminary report.
Serum Uric Acid Lowering Treatment Appears Unnecessary during Hemodialysis.
PATTERNS OF INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS AND ABATACEPT. MULTICENTER STUDY OF 63 PATIENTS
Clinical activity, ultrasound assessment and drug monitoring in rheumatoid arthritis patients receiving ANTI-TNF-¿ therapy with extended interval of administration
Systemic lupus erythematosus and gout: really an unusual association?
IDENTIFICATION OF GENETIC VARIATION SPECIFICALLY ASSOCIATED WITH PSORIATIC ARTHRITIS USING GENOME-WIDE ASSOCIATION STUDIES
Patients with chronic inflammatory arthropathies treated with golimumab achieve a higher serum level of drug if used as the first or second biological drug
Practical Skill Session: Crystal analysis I
EULAR ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY
THE PROFILES OF PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THEIR BELIEFS IN THEIR BIOLOGICAL DRUGS. ARCO STUDY
BACTEREMIA IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS FROM RELESSER REGISTRY: RISK FACTORS, CLINICAL AND MICROBIOLOGICAL CHARACTERISTICS AND OUTCOMES
RDF description of EULAR ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY - http://research.umh.es/vivo/pub/congreso/116002